NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,491 | +1.0% | 3,303 | 0.0% | 0.15% | +0.7% |
| Q2 2023 | $333,306 | +9.7% | 3,303 | 0.0% | 0.15% | +5.5% |
| Q1 2023 | $303,876 | +4.6% | 3,303 | +3.1% | 0.14% | -3.3% |
| Q4 2022 | $290,576 | +19.6% | 3,203 | 0.0% | 0.15% | +5.6% |
| Q3 2022 | $243,000 | -7.3% | 3,203 | +3.2% | 0.14% | -3.4% |
| Q2 2022 | $262,000 | -4.4% | 3,103 | -0.7% | 0.15% | 0.0% |
| Q1 2022 | $274,000 | +0.4% | 3,126 | 0.0% | 0.15% | 0.0% |
| Q4 2021 | $273,000 | +6.6% | 3,126 | 0.0% | 0.15% | 0.0% |
| Q3 2021 | $256,000 | -6.2% | 3,126 | +4.3% | 0.15% | -11.4% |
| Q2 2021 | $273,000 | +18.7% | 2,996 | +11.1% | 0.17% | +12.2% |
| Q1 2021 | $230,000 | -34.5% | 2,696 | -27.5% | 0.15% | -31.2% |
| Q4 2020 | $351,000 | +12.1% | 3,719 | +3.3% | 0.22% | +0.5% |
| Q3 2020 | $313,000 | +17.2% | 3,601 | +17.4% | 0.21% | +4.9% |
| Q2 2020 | $267,000 | -1.8% | 3,066 | +6.5% | 0.20% | +0.5% |
| Q4 2019 | $272,000 | – | 2,879 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |